Ajooni’s Moo-ving Up: ₹48 Million Win in Livestock Nutrition Has Investors Grazing for More

Ajooni Biotech Ltd., one of India’s emerging leaders in animal nutrition and livestock feed solutions, has announced a significant milestone in its business trajectory—an order worth ₹48 million from one of Asia’s largest and India’s top 10 dairy suppliers. This development marks a strategic leap forward for the company, reinforcing its position in the competitive animal health and feed industry.

 

Order Details and Strategic Importance

The ₹48 million order, which is part of a broader ₹49.5 million procurement agreement, centers around Ajooni Biotech’s cattle feed products. The client, a major player in the dairy sector, has expressed strong interest in Ajooni’s high-quality feed formulations designed to enhance milk yield, animal health, and overall farm productivity.

 

According to the company’s statement, the order is expected to be fulfilled within a three-month window, showcasing Ajooni’s operational efficiency and supply chain readiness. This swift turnaround is critical, given the seasonal demand cycles in the dairy industry and the need for consistent feed supply to maintain livestock health.

 

Product Portfolio and Innovation

Ajooni Biotech has built its reputation on a diverse portfolio of livestock feeds and supplements. These include:

The company’s products are developed using modern technologies such as ERP systems and PLC-controlled production processes, ensuring consistency and quality across batches. Ajooni’s manufacturing facilities are ISO 9001:2015 certified and registered with the Bureau of Indian Standards (BIS), further validating its commitment to excellence.

 

Sustainability and R&D Focus

Beyond commercial success, Ajooni Biotech is deeply invested in sustainable agriculture and animal health. The company recently launched an innovative Moringa-based nutrition project in Bikaner aimed at boosting livestock productivity while contributing to renewable energy initiatives. Collaborations with leading universities and independent scientists have enabled Ajooni to stay ahead of the curve in research-driven feed solutions.

 

This order aligns with the company’s broader mission to support dairy farmers with cost-effective, high-performance feed products that improve yield and reduce input costs.

 

Financial Outlook and Market Position

The announcement comes on the heels of Ajooni’s successful rights issue in May 2024, which raised ₹43.81 crores and was oversubscribed by 1.08 times. The capital infusion has been earmarked for land acquisition, plant and machinery upgrades, and working capital needs—investments that are now bearing fruit.

 

Ajooni’s financials reflect steady growth, with revenue increasing by 0.95% and profit after tax rising by 7.23% between FY 2022 and FY 2023. The company’s net worth has also seen a substantial uptick, signaling investor confidence and operational resilience.

 

Strategic Partnerships and Expansion

In recent months, Ajooni has entered into strategic partnerships with Avalon Energy Group LLC (USA) and Avalon Bioenergy Pvt. Ltd., expanding its footprint in the renewable energy and bio-nutrition sectors. Additionally, collaborations with the National Dairy Development Board and Unati Agri-Allied Cooperative Society have opened new avenues for distribution and product development.

 

These alliances are expected to bolster Ajooni’s market reach and diversify its revenue streams, making it a formidable player in both domestic and international markets.

 

Industry Reaction

Market analysts view the ₹48 million order as a strong vote of confidence in Ajooni’s product quality and delivery capabilities. Given the increasing demand for scientifically formulated livestock feed in India’s booming dairy sector, Ajooni is well-positioned to capitalize on future opportunities.

 

The order also reflects a broader trend in agribusiness where corporates are prioritizing reliable, research-backed suppliers to meet the nutritional demands of high-yield livestock.

 

Sources: MarketScreener, Chittorgarh, Ajooni Biotech